Ellice Wong, MD
DownloadHi-Res Photo
Cards
Appointments
Medical Oncology
Primary
Titles
Director, Newington VA Hematology/Oncology Service
Contact Info
Faculty: Medical Oncology-Hematology Program
950 Campbell Ave, 111D
West Haven, CT 06516
United States
Appointments
Medical Oncology
Primary
Titles
Director, Newington VA Hematology/Oncology Service
Contact Info
Faculty: Medical Oncology-Hematology Program
950 Campbell Ave, 111D
West Haven, CT 06516
United States
Appointments
Medical Oncology
Primary
Titles
Director, Newington VA Hematology/Oncology Service
Contact Info
Faculty: Medical Oncology-Hematology Program
950 Campbell Ave, 111D
West Haven, CT 06516
United States
About
Titles
Assistant Professor of Medicine (Medical Oncology)
Director, Newington VA Hematology/Oncology ServiceAppointments
Medical Oncology
Assistant ProfessorPrimary
Other Departments & Organizations
Education & Training
- Residency
- New York University Medical Center (2007)
- MD
- New York Medical College (2004)
- BS
- Yale University, Molecular Biophysics & Biochemistry (2000)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Ellice Wong's published research.
Publications Timeline
A big-picture view of Ellice Wong's research output by year.
Michal Rose, MD
Natalia Neparidze, MD
Amy Justice, MD, PhD
Patrick Gallagher, MD, BS
Roxanne Wadia, MD
12Publications
19Citations
Publications
2023
- Wong EY, Rose MG. Update on MDS for Cancer: Principles & Practice of Oncology, 12th edition, 2023.Commentaries, Editorials and Letters
- Wong EY, Rose MG. Update on CML for Cancer: Principles & Practice of Oncology, 12th edition, 2023.Commentaries, Editorials and Letters
- Wong EY, Rose MG. Update on CLL for Cancer: Principles & Practice of Oncology, 12th edition, 2023.Commentaries, Editorials and Letters
2020
- Wong E, Rose MG, Berliner N. Disorders of red blood cells. In: Wing E. and Shiffman F. eds. Cesil Essentials of Medicine, 10th ed. Elsevier 2020.Chapters
- Wong E, Rose MG and Berliner N. Clinical Disorders of Granulocytes and Monocytes. In: Wing E. and Schiffman F. eds. Cecil Essentials of Medicine, 10th ed. Elsevier 2020.Chapters
2019
Multicenter phase II trial of RRx-001 in previously treated SCLC.
Morgensztern D, Rose M, Morris J, Ma P, Brzezniak C, Zeman K, Padmanabhan A, Hirth J, Spira A, Wong E, Padda S, Waqar S. Multicenter phase II trial of RRx-001 in previously treated SCLC. Journal Of Clinical Oncology 2019, 37: e20104-e20104. DOI: 10.1200/jco.2019.37.15_suppl.e20104.Peer-Reviewed Original ResearchConceptsSmall cell lung cancerRRx-001Partial responseStable diseaseOverall survivalPrior linesCommon treatment-emergent adverse eventsSingle-arm phase II studyArm phase II studyMulticenter phase II trialTreatment-emergent adverse eventsPhase II studyPhase II trialPlatinum-resistant diseaseCell lung cancerOverall response rateTreat populationII trialPrimary endpointAdverse eventsEtoposide chemotherapyII studyComplete responsePlatinum therapyLung cancer
2018
Impact of HIV on Clinical Presentation and Outcomes of Individuals with Multiple Myeloma
Giri S, Wong E, Rose M, Wadia R, Park L, Justice A, Neparidze N. Impact of HIV on Clinical Presentation and Outcomes of Individuals with Multiple Myeloma. Blood 2018, 132: 3162. DOI: 10.1182/blood-2018-99-115633.Peer-Reviewed Original ResearchConceptsVeterans Aging Cohort StudyMultiple myelomaEM diseaseUninfected patientsClinical characteristicsLytic lesionsOutcome of MMRisk of MMImpact of HAARTRole of HAARTStage 3 diseaseSymptomatic multiple myelomaTime of diagnosisAggressive clinical courseAging Cohort StudyClinical outcome dataCourse of diseasePlasma cell disordersDurie-Salmon stageVeterans Health AdministrationImpact of HIVSignificant differencesStage 1High rateStage 2Targeting Protein Disulfide Isomerase with the Oral Flavonoid Isoquercetin Prevents Venous Thromboembolism in Advanced Cancer: Results of a Multi-Dose, Multi-Center, Phase II Clinical Trial (CATIQ Study)
Zwicker J, Schlechter B, Stopa J, Liebman H, Aggarwal A, Caughey T, Bauer K, Kuemmerle N, Wong E, Wun T, Mclaughlin M, Puligandla M, Neuberg D, Furie B, Flaumenhaft R. Targeting Protein Disulfide Isomerase with the Oral Flavonoid Isoquercetin Prevents Venous Thromboembolism in Advanced Cancer: Results of a Multi-Dose, Multi-Center, Phase II Clinical Trial (CATIQ Study). Blood 2018, 132: 985. DOI: 10.1182/blood-2018-99-114946.Peer-Reviewed Original ResearchAltmetricConceptsVenous thromboembolismDay 56Major hemorrhageAdvanced cancerAntithrombotic efficacyCancer patientsHigh riskThrombus formationD-dimer plasma concentrationIncidence of VTEPlasma D-dimer levelsNon-small cell lungPhase II clinical trialPlatelet-dependent thrombin generationPrevent Venous ThromboembolismPhase II studySecond-line chemotherapySymptomatic pulmonary embolismD-dimer levelsLower extremity DVTPhase II trialMonths of initiationLower extremity ultrasoundSoluble P-selectinInitial human studiesQUADRUPLE THREAT: A phase II trial of RRx-001 followed by etoposide-platinum re-challenge in previously treated small cell lung cancer.
Padda S, Brzezniak C, Waqar S, Wakelee H, Ma P, Rose M, Reid T, Spira A, Wong E, Zeman K, Oronsky B, Abrouk N, Morgensztern D. QUADRUPLE THREAT: A phase II trial of RRx-001 followed by etoposide-platinum re-challenge in previously treated small cell lung cancer. Journal Of Clinical Oncology 2018, 36: e20575-e20575. DOI: 10.1200/jco.2018.36.15_suppl.e20575.Peer-Reviewed Original ResearchCitations
2014
Electronic Hematology Consultations at Veterans Affairs (VA) Connecticut: Analysis of Effects on Patient Care, and Provider and Patient Satisfaction
Neparidze N, Cecchini M, Wong E, Rose M. Electronic Hematology Consultations at Veterans Affairs (VA) Connecticut: Analysis of Effects on Patient Care, and Provider and Patient Satisfaction. Blood 2014, 124: 4857. DOI: 10.1182/blood.v124.21.4857.4857.Peer-Reviewed Original ResearchConceptsElectronic medical recordsHematology consultationTimeliness of careE-consultsFace visitsHematology clinicPatient satisfactionProvider satisfactionPatient careAbnormal coagulation profileMajority of patientsComprehensive electronic medical recordsPeripheral blood smearUnnecessary patient visitsNumber of veteransHealthcare delivery methodsVenous thromboembolismMedical chartsCoagulation profileRetrospective reviewAddition patientsPatient preferencesMedical recordsPatient visitsIron indices
Academic Achievements and Community Involvement
activity Member
CommitteesLCME Education Subcommittee, Yale School of MedicineDetails2022 - Presentactivity Member
Professional OrganizationsAmerican Society of HematologyDetails2008 - Presentactivity Member
CommitteesVA CT Healthcare System Cancer CommitteeDetails2008 - Presentactivity Co-Chair
CommitteesVA CT Healthcare System Blood Utilization CommitteeDetails2014 - Presentactivity Member
CommitteesVA CT Healthcare System COVID-19 Treatment CommitteeDetails2020 - Present
Links & Media
Get In Touch
Contacts
Email
Mailing Address
Faculty: Medical Oncology-Hematology Program
950 Campbell Ave, 111D
West Haven, CT 06516
United States